Physician profile
Amy A Werner
NPI 1770048522
$1,094.83
in general payments reported to CMS, 2019-2025
20 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.82 · 2022: $99.72 · 2023: $247 · 2024: $357 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $218.63 | 2023-2024 | |
| Novo Nordisk INC | $184.02 | 2022-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $155.87 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $108.52 | 2021-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $96.18 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $57.53 | 2024 | |
| Abbvie INC. | $40.85 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.99 | 2025 | Xifaxan |
| Glaxosmithkline, LLC. | $29.06 | 2023-2025 | Bexsero, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.46 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $15.81 | 2025 | Ajovy |
| Phathom Pharmaceuticals, INC. | $15.33 | 2025 | Voquezna |
| Amgen INC. | $15.01 | 2023 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $14.51 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.48 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $14.28 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.06 | 2022 | |
| Amarin Pharma, INC. | $13.85 | 2022 | |
| Horizon Therapeutics Plc | $13.46 | 2021 | |
| Hologic Sales and Service, LLC | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Werner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.